M. Munarques et al., FAMILIAL AMYLOIDOTIC POLYNEUROPATHY - TTR-MET-30 IN MAJORCA (SPAIN), AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 4(3), 1997, pp. 181-186
We analyzed data from 78 Majorcan patients with familial amyloidotic p
olyneuropathy (FAP): 57 confirmed and 21 non-confirmed. Diagnosis was
established in the first group by histopathological study or defection
of the biochemical marker in serum, and in the second was supported b
y clinical information and family history. Eighteen confirmed patients
were isolated cases and 39 had a family history of FAP Age of onset w
as 46.7 years; later in males; predominance of males (72%) and late on
set cases (65%). The TTR variant was Met 30 associated with haplotype
I. Initial sensorimotor syndrome was present only in 55% of patients.
Multiple progressive handicaps appeared. Duration averaged 10.5 years
and was longer in males. Prevalence rare was 3.3 patients per 100,000
and asymptomatic carriers were 83. Twelve patients underwent liver tra
nsplantation. Since 1989, the number of FAP families, patients, preval
ence, isolated cases and municipalities with affected families was inc
reased. One founder hypothesis is supported the mutation probably arri
ved from Portugal, The Majorcan focus is the fifth largest in the worl
d. Age of onset lies between that of Sweden and those of Portugal, Jap
an and Brazil. Early diagnosis is very important for the possible indi
cation of liver transplantation. FAP constitutes a public health probl
em in Majorca.